CPRIT: Patient Adherence to Lung Cancer Screening

Last updated: March 31, 2025
Sponsor: M.D. Anderson Cancer Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Lung Cancer Screening

Clinical Study ID

NCT06872723
2024-1489
  • Ages 50-80
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Current smoker or quit within the past 15 years

  • A 20+ pack-year smoking history

  • Healthy enough for treatment

Exclusion

Exclusion Criteria:

  • Not applicable as our focus is on patients with an order for screening at the UTMBor UT Tyler

Study Design

Total Participants: 340
Treatment Group(s): 1
Primary Treatment: Lung Cancer Screening
Phase:
Study Start date:
March 21, 2025
Estimated Completion Date:
February 28, 2031

Study Description

Primary Objectives/Aims

  1. Determine rates of lung cancer scheduling and screening at the UTMB and UT Tyler LCS programs.

  2. Using state-of-the-art machine learning (ML) approaches, develop prediction models for adherence to screening guidelines for newly eligible and established patients. Investigators will leverage data from BRFSS, UT Tyler and UTMB to develop and validate the prediction model, ensuring its generalizability and accuracy.

  3. Survey participants in the LCS programs about their impressions and experience with the scheduling and completing screening; conduct interviews with participants who receive an order for LCS but do not complete screening by their due date.

  4. Interview LCS program directors and staff about barriers and facilitators of increasing screening rates in their programs.

Connect with a study center

  • MD Anderson Cancer Center

    Houston, Texas 77030
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.